Last reviewed · How we verify
Vehicle of Zylet — Competitive Intelligence Brief
marketed
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vehicle of Zylet (Vehicle of Zylet) — Bausch & Lomb Incorporated. The vehicle of Zylet is an inert pharmaceutical formulation base that serves as the delivery medium for the active pharmaceutical ingredients loteprednol etabonate and tobramycin.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vehicle of Zylet TARGET | Vehicle of Zylet | Bausch & Lomb Incorporated | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vehicle of Zylet CI watch — RSS
- Vehicle of Zylet CI watch — Atom
- Vehicle of Zylet CI watch — JSON
- Vehicle of Zylet alone — RSS
Cite this brief
Drug Landscape (2026). Vehicle of Zylet — Competitive Intelligence Brief. https://druglandscape.com/ci/vehicle-of-zylet. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab